Registered entities
Prophylix AS
Reg. No. 920056261Norway
Investor mix
2 investors on record; lead investors include Norinnova Invest, Sarsia Seed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 100% |
Developer of antibodies for the treatment of fetal and neonatal alloimmune thrombocytopenia (FNAIT)
2 investors on record; lead investors include Norinnova Invest, Sarsia Seed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 100% |